(MedPage Today) — Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don’t require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard triple-drug regimens.
The…
Source link : https://www.medpagetoday.com/spotlight/hiv/116814
Author :
Publish date : 2025-08-04 17:18:00
Copyright for syndicated content belongs to the linked Source.
